Results 91 to 100 of about 31,621 (232)

Evaluation of Efficacy of Plasmapheresis in Nephrology Practice: A Single Center Experience

open access: yesTurkish Journal of Nephrology, 2019
Plasmapheresis is a method of cleaning the high molecular weight solutes such as immune complexes, protein-bound toxins, autoantibodies, cryoglobulins, myeloma light chains, and endotoxins from the extracorporeal blood plasma with removal techniques ...
Battal ALTUN   +9 more
doaj  

Plasmapheresis for treatment of pulmonary alveolar proteinosis.

open access: yes, 2009
Whole lung lavage (WLL) is currently the standard therapy for pulmonary alveolar proteinosis (PAP). Nevertheless, some PAP patients respond poorly to WLL or require it frequently.
B. C. Trapnell   +6 more
core   +1 more source

Plasmapheresis in Neonatal Lupus

open access: yes, 2022
About 2% of mothers with Sjögren’s syndrome and about 1% of mothers with systemic lupus erythematosus deliver a baby with a congenital heart block (CHB).
Angelica S. J. Scribner   +2 more
core   +1 more source

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

open access: yesTransfusion, EarlyView.
Abstract Background During the COVID‐19 pandemic, convalescent plasma (CP) was investigated as a potential treatment. We assess the financial resources required to implement a COVID‐19 CP (CCP) programme and provide recommendations on how best to prepare for collection and use of CP in future pandemics.
Elizabeth A. Stokes   +5 more
wiley   +1 more source

Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital

open access: yesThe Turkish Journal of Pediatrics, 2020
Background. Our study aimed to compare the outcome of different therapeutic modalities for the management of children with Guillain-Barré syndrome (GBS) and to identify the associating risk factors that may affect the course and prognosis of the ...
Zeinab M Mohy-Eldeen   +3 more
doaj   +1 more source

Voluntary non‐remunerated plasma collection in Denmark: Experiences from the Central Denmark Region

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives In Denmark, increasing demand for plasma‐derived medicinal products has made plasma self‐sufficiency based on voluntary, non‐remunerated donation a political priority. This report describes recent developments in plasma collection, with a focus on the Central Denmark Region.
Kathrine Agergård Kaspersen   +14 more
wiley   +1 more source

A 45 min bout of hot‐water immersion induces transient plasma volume contraction without a detectable increase in circulating erythropoietin

open access: yesExperimental Physiology, EarlyView.
Abstract Heat acclimation is increasingly used to induce haematological adaptations and enhance endurance performance. Although repeated hot‐water immersion (HWI) has been shown to increase haemoglobin mass, the acute physiological responses that might underpin these longer‐term adaptations remain poorly understood.
Owain Zerilli   +6 more
wiley   +1 more source

Therapeutic Plasmapheresis: Indications and Clinical Outcomes

open access: yesJournal of Education, Health and Sport
Therapeutic plasma exchange is a procedure that involves separating plasma from the cellular components. The plasma that is taken out is discarded and swapped with a solution that includes both crystalloid and colloid components or fresh frozen plasma ...
Justyna Ignarska   +4 more
doaj   +1 more source

The effect of plasmapheresis on plasma cholinesterase levels in a patient with organophosphate poisoning

open access: yes, 2004
Objective: To describe the role of plasmapheresis in management of organophosphate poisonings. Design: Case report. Setting: A medical intensive care unit of a medical faculty. Patient: A patient with organophosphate poisoning whose cholinesterase levels
Eser, Bülent   +2 more
core   +1 more source

Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction

open access: yes, 2022
We share our experience of a patient with pulmonary alveolar proteinosis who was refractory to plasmapheresis and rituximab despite a significant reduction in the offending antibody. He presented with shortness of breath, fevers, chills, and sweats for 4
Aysenur Keske   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy